» Articles » PMID: 28819975

Compatibility of Nitric Oxide Release with Implantable Enzymatic Glucose Sensors Based on Osmium (III/II) Mediated Electrochemistry

Overview
Journal ACS Sens
Specialty Biotechnology
Date 2017 Aug 19
PMID 28819975
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The compatibility of nitric oxide (NO) release coatings with implantable enzymatic glucose sensors based on osmium (III/II) mediated electrochemical detection is examined for the first time. NO-releasing osmium-mediated glucose sensors are prepared using a S-nitrosothiol impregnated outer tubing and are tested in vitro in both phosphate buffer (pH 7.4) and whole porcine blood. It is demonstrated that after 3 days of continuous NO release at or above physiological levels, there are no negative effects on the osmium mediated electrochemical currents. Indeed, such sensors maintain their functionality, sensitivity, and accuracy for detecting glucose levels in blood. The results suggest that improved performance of both intravascular and, potentially, subcutaneous Os(III/II) mediated glucose sensors may be realized by taking advantage of NO's well-known anticlotting, anti-inflammatory, and antimicrobial properties.

Citing Articles

Optimized Copper-Based Microfeathers for Glucose Detection.

Guati C, Gomez-Coma L, Fallanza M, Ortiz I Biosensors (Basel). 2023; 13(12).

PMID: 38131792 PMC: 10741577. DOI: 10.3390/bios13121032.


Modulating the foreign body response of implants for diabetes treatment.

Kharbikar B, Chendke G, Desai T Adv Drug Deliv Rev. 2021; 174:87-113.

PMID: 33484736 PMC: 8217111. DOI: 10.1016/j.addr.2021.01.011.


Studies of combined NO-eluting/CD47-modified polyurethane surfaces for synergistic enhancement of biocompatibility.

Zhang Q, Stachelek S, Inamdar V, Alferiev I, Nagaswami C, Weisel J Colloids Surf B Biointerfaces. 2020; 192:111060.

PMID: 32450498 PMC: 7572543. DOI: 10.1016/j.colsurfb.2020.111060.


Zinc-oxide nanoparticles act catalytically and synergistically with nitric oxide donors to enhance antimicrobial efficacy.

Singha P, Workman C, Pant J, Hopkins S, Handa H J Biomed Mater Res A. 2019; 107(7):1425-1433.

PMID: 30737882 PMC: 6527449. DOI: 10.1002/jbm.a.36657.


Nitric Oxide Release for Improving Performance of Implantable Chemical Sensors - A Review.

Cha K, Wang X, Meyerhoff M Appl Mater Today. 2018; 9:589-597.

PMID: 29520370 PMC: 5837052. DOI: 10.1016/j.apmt.2017.10.002.

References
1.
Sato Y, Hiramatsu Y, Homma S, Sato M, Sato S, Endo S . Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation. J Thorac Cardiovasc Surg. 2005; 130(2):346-50. DOI: 10.1016/j.jtcvs.2004.12.028. View

2.
Kim S, Jacobs H . Design of nonthrombogenic polymer surfaces for blood-contacting medical devices. Blood Purif. 1996; 14(5):357-72. DOI: 10.1159/000170288. View

3.
Vanhorebeek I, Langouche L, Van den Berghe G . Tight blood glucose control with insulin in the ICU: facts and controversies. Chest. 2007; 132(1):268-78. DOI: 10.1378/chest.06-3121. View

4.
Pant J, Goudie M, Hopkins S, Brisbois E, Handa H . Tunable Nitric Oxide Release from S-Nitroso-N-acetylpenicillamine via Catalytic Copper Nanoparticles for Biomedical Applications. ACS Appl Mater Interfaces. 2017; 9(18):15254-15264. PMC: 8007131. DOI: 10.1021/acsami.7b01408. View

5.
Chen X, Matsumoto N, Hu Y, Wilson G . Electrochemically mediated electrodeposition/electropolymerization to yield a glucose microbiosensor with improved characteristics. Anal Chem. 2002; 74(2):368-72. DOI: 10.1021/ac015628m. View